Ambalal Sarabhai Enterprises Ltd

BSE
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

Start SIP in Ambalal Sarabhai Enterprises Ltd
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
34.36% Fall from 52W High
-21.8
TTM PE Ratio
High in industry
122.1
Price to Book Ratio
Below industry Median
2.7
Dividend yield 1yr %
0
TTM PEG Ratio
PEG TTM is negative
-1.6
RSI
RSI is mid-range
45.9
MFI
MFI is mid-range
46.1

Ambalal Sarabhai Enterprises Ltd Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Ambalal Sarabhai Enterprises Ltd shareholding Pattern

Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%
Promoter
30.8%
Public
69.2%

Ambalal Sarabhai Enterprises Ltd Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
2
Bearish Moving Averages
14
5Day EMA
46.80
10Day EMA
46.70
12Day EMA
46.70
20Day EMA
46.80
26Day EMA
47.00
50Day EMA
47.90
100Day EMA
47.60
200Day EMA
44.10
5Day SMA
47.40
10Day SMA
46.60
20Day SMA
46.20
30Day SMA
46.80
50Day SMA
47.20
100Day SMA
50.40
150Day SMA
47.10
200Day SMA
44.00
Delivery & Volume
Resistance & Support
46.41
Pivot
Resistance
First Resistance
47.03
Second Resistance
48.10
Third Resistance
48.72
Support
First Support
45.34
Second support
44.72
Third Support
43.65
Relative Strength Index
45.90
Money Flow Index
46.06
MACD
-0.28
MACD Signal
-0.52
Average True Range
2.68
Average Directional Index
14.96
Rate of Change (21)
-3.28
Rate of Change (125)
-2.28
Peer comparison
Compare
Company
Market Price
Market Cap
52W Low
52W High
Lyka Labs Ltd.
363.16
89
143.5
Ambalal Sarabhai Enterprises Ltd.
-
-
-
Jenburkt Pharmaceuticals Ltd.
-
-
-
Kerala Ayurveda Ltd.
-
-
-
Gennex Laboratories Ltd.
-
-
-
Zenotech Laboratories Ltd.
-
-
-
Fredun Pharmaceuticals Ltd.
-
-
-

Ambalal Sarabhai Enterprises Ltd Company background

Founded in: 1977
Managing director: Mohal Kartikeya Sarabhai
Ambalal Sarabhai Enterprises Ltd., incorporated on June 5, 1978, houses a range of companies across multidimensional businesses. Each subsidiary is a distinct entity contributing its unique expertise and capabilities. It is one of the oldest pharmaceutical health care companies in India, and today through its group companies it manufactures and markets pharmaceutical, molecular diagnostics, and electronics products in India and internationally. ASEs strength is to lead with cutting edge technology by creating strategic technology tieups and collaborative partnerships through our broad national and international networksThe Company produces a range of bulk drugs, pharmaceutical preparations and electronic instruments. It operates in two segments, pharmaceuticals and electronics. Pharmaceuticals segment is engaged in manufacture of drugs and formulations. Electronics segment is engaged in manufacture of electronics instruments and services. In the year 1994, the company entered into a technical collaboration with Biobras, Brazil, to manufacture highly purified insulin injections. During the year 199798, the company formed a joint venture company, namely Sarabhai Piramal Pharmaceuticals Ltd with Piramal Enterprises Ltd for marketing of certain products under trademarks being used by the company. During the year 199899, the company signed agreement with B V Chiron, Netherlands for introducing their anticancer drugs in India.During the year 19992000, the company entered into an MoU for marketing of products of Oncology products of Chiron Corporation, USA. The Product Division essentially comprising of Sarabai Chemicals Products was transferred to the joint venture company, Sarabhai Piramal Pharmaceuticals Ltd. In September 2008, the company acquired the manufacturing and marketing company, namely Suvik Hitek Pvt. Ltd. The Ethical Division relaunched the products of Suvik and Sarabhai Chemicals in market. Also, the company acquired Systronics (India) Pvt Ltd. During the year 200809, the Oncology Division launched two new products viz. Fludagem Xtinib. Also, the company promoted a company viz. Vovanties Laboratories Pvt Ltd, a pharmaceutical specialist with a vision to establish a state of the art manufacturing facility specializing in Novel Effervescent Drug Delivery System. During the year 201011, the Company had transferred and assigned as going concern, the business undertaking of Sarabhai Chemicals Bulk Drug Division to Synbiotics Ltd and Electronics Division comprising of Systronics, Teleradand SERC to Systronics (India) Ltd with effect from October 01, 2010.Sarabhai M Chemicals Ltd, a wholly owned subsidiary company started its Vitamin C coated products manufacturing since August 2019.In June 2023, Asence Pharma Pvt., Ltd. a subsidiary of the Company commenced its new oncology and synthetic API plant at Ranoli, Vadodara.
Read More

Ambalal Sarabhai Enterprises Ltd FAQs

The past 1-year return of Ambalal Sarabhai Enterprises Ltd [AMBASARABH] share was 114.21. The Ambalal Sarabhai Enterprises Ltd [AMBASARABH] share hit a 1-year low of Rs. 20.9 and a 1-year high of Rs. 70.

You can easily buy Ambalal Sarabhai Enterprises Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
or Resume your Application
+91 -

personImage